Institutional Investors Amplify Stakes in Victoria’s Secret Ahead of Earnings

Victoria's Secret & Company US9264001028

A notable accumulation of shares by major funds is drawing attention to Victoria's Secret & Co. Market participants are observing this activity as the company approaches the release of its full-year 2025 results, a report that will test whether holiday season performance met market expectations.

Key Upcoming Milestones:
* Full-Year 2025 Earnings Release: February 26, 2026
* 2025 Revenue Guidance: $6.45 billion to $6.48 billion
* 2025 Adjusted Operating Income Forecast: $350 million to $375 million
* Q3 2025 International Growth: Exceeded 30%

Recent regulatory filings revealed a substantial increase in position by Y Intercept Hong Kong Ltd. The institutional investor boosted its holdings by approximately 362% during the last reporting period, bringing its total stake to 84,410 shares. This move comes at a critical juncture, with the entire retail sector awaiting conclusive data from the crucial holiday shopping period.

This institutional buying aligns with a period of stabilized financial performance for the company. For the third quarter of 2025, Victoria's Secret reported net sales of $1.47 billion, marking a 9% increase compared to the same period the prior year.

International Expansion and Corporate Governance in Focus

Analysts identify international operations, particularly in China, as a pivotal growth engine for future valuation. The company's digital performance in the Chinese market has recently been a strong contributor to overall expansion and is anticipated to be a central topic during the upcoming February 26 earnings discussion. Management faces the task of demonstrating that momentum in overseas markets can continue to offset slower growth in more mature regions.

Furthermore, a shareholder rights plan enacted in May 2025 remains a point of consideration for long-term corporate governance. This plan is set to expire on May 18, 2026. The market is monitoring whether this provision will contribute to share price stability throughout the company's ongoing strategic repositioning.

All eyes are now on the annual report scheduled for late February. A key metric will be whether the adjusted operating income meets or surpasses the upper end of its guided range at $375 million. Should the company fail to achieve its stated targets, the recent confidence displayed by institutional buyers could be swiftly challenged.

@ boerse-global.de | US9264001028 INSTITUTIONAL